ISU MEMORANDUM/ MEDICAL FIGURE SKATING The ISU Medical Commission is appointed to assist local Organizing Committees and to report to the ISU Council on medical and Anti-Doping matters. Rule 140 of the ISU General Regulations requires that the Organizing Committees of ISU Events provide emergency medical services for all participants at the competition and practice sites. Details of the p
LkldkflkdddALVARO GARZA, M.D., M.P.H.
SAN BENITO COUNTY MARIA C. CORONA
PUBLIC HEALTH SERVICES
Healthy People in Healthy Communities
FOR IMMEDIATE RELEASE
CONTACT: Allison Griffin, PHN
September 10, 2012
Communicable Disease Nurse, (831) 637-5367
To: Primary Healthcare Providers, OB/GYNs, Community Clinics & Emergent Care
Health Update: New GC Treatment Guidelines from the CDC
Since December 2010, the Centers for Disease Control and Prevention (CDC) have recommended that health care providers treat uncomplicated gonorrhea (GC for gonococcal) infections with dual antibiotic therapy: ceftriaxone 250 mg intramuscularly (IM) plus azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days. If ceftriaxone was not an option, the oral antibiotic cefixime at a dose of 400 mg with either azithromycin or doxycycline was also a recommended therapy. In a recent Morbidity and Mortality Weekly Report (MMWR), the CDC released new data indicating an increase in the proportion of GC isolates tested through the GC Isolate Surveillance Project (GISP) with “alert values” to cephalosporin antibiotics including cefixime and ceftriaxone. The alert values serve as a warning sign that cephalosporin resistance may be developing. In 2011, the highest proportions of GC isolates with elevated minimum inhibitory concentrations (MICs) to cefixime are in the west (3.2%) and among men who have sex with men (MSM) (3.8%). It is important to note that these are only a warning sign of resistance -- cases of treatment failure due to cephalosporin resistance have not yet been seen in the U.S. Given these new data, the CDC have changed the status of oral cefixime from a
recommended to an alternative treatment. Because IM cephalosporins are less likely to
induce resistance, dual therapy with ceftriaxone plus azithromycin or doxycycline is now the
only recommended therapy for uncomplicated GC infections. The use of azithromycin as the
second antimicrobial is preferred to doxycycline because of the advantages of single-dose
therapy and the higher prevalence of tetracycline resistance. For patients allergic to
cephalosporins, azithromycin 2 g orally in a single dose is still considered an alternative
The full report, “Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections” (MMWR Weekly, August 10, 2012 / 61(31);590-594), is available online: The California Gonorrhea Treatment Guidelines will be updated to reflect new national guidance and posted online: Health Alert: Warrants immediate action or attention.
Health Advisory: Provides information for a specific incident or situation; may not require immediate action.
Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action.
MEDICAL THERAPY UNIT
Accord national médico-mutualiste 2009–2010 ACCORD NATIONAL MEDICO-MUTUALISTE 2009–2010 En vertu des articles 26, 50 et 51 de la loi relative à l’assurance obligatoire soins de santé et indemnités, coordonnée le 14 juillet 1994, la Commission nationale médico-mutualiste (dénommée ci-après CNMM), sous la Présidence de M. Johan DE COCK, a conclu le 17 décembre 2008, l’accord